BSE filing, NSE: KFBL. Summary written from the filing by ALFA Finder's alert engine.
Kothari Fermentation & Biochem Ltd: key numbers
- Share price
- ₹40.21
- Market cap
- ₹60.32 Cr
- Revenue (annual)
- ₹112.1 Cr
- Net profit (annual)
- ₹-2.99 Cr
- P/E (TTM)
- -28.5×Sector 27.1×
- Promoter holding
- 68.87%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kothari Fermentation & Biochem Ltd
All →Kothari Fermentation & Biochem Other Announcement
Kothari Fermentation & Biochem Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Kothari Fermentation & Biochem Partnership
KFBL signed a commercial tie-up with Oriental Yeast India Private Limited for yeast distribution, manufacturing, and technical support. No upfront consideration; no new entity formed.
Kothari Fermentation & Biochem Annual General Meeting
Kothari Fermentation & Biochem Ltd held its 36th Annual General Meeting on September 30, 2026, to transact various ordinary and special business items.
Kothari Fermentation & Biochem Management Change
Kothari Fermentation and Biochem Ltd announced the resignation of M/s. Arun K. Garg & Associates as the Internal Auditor, effective from September 25, 2026.
Kothari Fermentation & Biochem Other Announcement
Kothari Fermentation dispatched a Reg 36(1)(b) web-link letter to physical shareholders. It provides access to the FY 2025-26 AGM notice and annual report.
Kothari Fermentation & Biochem Annual General Meeting
Kothari Fermentation and Biochem Ltd issued the notice for its 36th AGM, scheduled for September 30, 2026. The meeting will also consider revised director remuneration resolutions.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.